Viewing Study NCT03944460

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:04 AM
Ignite Modification Date: 2026-02-18 @ 12:56 AM
Study NCT ID: NCT03944460
Status: COMPLETED
Last Update Posted: 2019-05-09
First Post: 2019-04-26
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: SAD Phase I Study (First-in-human) to Investigate Contraloid Acetate
Sponsor: Prof. Dr. Dieter Willbold
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Alzheimer Dementia View
None Alzheimer Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None anti-prionic View
None anti-Abeta-pionic View
None treatment of cognition and memory deficits View
None AD patients View
None AD stage-independent View
None NOT anti-amyloid View
None neuron specific Ca-ion reduction View